Track the Annexin Pharmaceuticals AB (publ) share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Annexin Pharmaceuticals AB (publ) has published 4 insider filings. Market capitalisation: €89.6m. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: Mikael Lönn. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
€2m
4 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €2mn/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
164,761 shares@ SEK 0.32100.0% of flowTeckningsoptionFI:A001P381-1
4 of 4 declarations
Acerca de Annexin Pharmaceuticals AB (publ)
Annexin Pharmaceuticals AB (publ) es una empresa farmacéutica sueca centrada en el desarrollo de tratamientos para enfermedades inflamatorias y trastornos cardiovasculares. Cotiza en la Bolsa de Estocolmo (XSTO).